Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.33 USD | +0.87% | -4.51% | -44.66% |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
25/04 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
Evolution of the average Target Price on CureVac N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CureVac N.V.
UBS | |
Leerink Partners | |
Kempen | |
alphavalue | Martin Schnee |
SVB Securities LLC | |
JMP Securities | |
Jefferies & Co. | |
BERENBERG | Zhiqiang Shu |
Berenberg Bank | |
BofA Securities | |
Deutsche Bank Securities | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- CVAC Stock
- Consensus CureVac N.V.